UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
Metal-Phenolic Nanomaterial with Organelle-Level Precision Primes Antitumor Immunity via mtDNA-dependent cGAS-STING Activation Journal article
Tian, Hao, Li, Wenxi, Wang, Guohao, Tian, Ye, Yan, Jie, Yu, Xinying, Yan, Ziliang, Feng, Yuzhao, Dai, Yunlu. Metal-Phenolic Nanomaterial with Organelle-Level Precision Primes Antitumor Immunity via mtDNA-dependent cGAS-STING Activation[J]. Angewandte Chemie - International Edition, 2024, e202411498.
Authors:  Tian, Hao;  Li, Wenxi;  Wang, Guohao;  Tian, Ye;  Yan, Jie; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:16.1/16.2 | Submit date:2024/11/05
Photodynamic Therapy  Mitochondria-targeted Pdt  Polyphenols  Mtdna Damages  Cgas-sting Pathway  
Targeting neutrophils potentiates hitchhiking delivery of drugs and agonists for postsurgical chemo-immunotherapy Journal article
Gao, Zhiliang, Wang, Ning, Ma, Yuan, Sun, Hongning, Li, Mengqi, Dai, Yunlu, Jiang, Xinyi, Ni, Shilei, Hao, Jingcheng, Cui, Jiwei. Targeting neutrophils potentiates hitchhiking delivery of drugs and agonists for postsurgical chemo-immunotherapy[J]. Nano Today, 2024, 54, 102096.
Authors:  Gao, Zhiliang;  Wang, Ning;  Ma, Yuan;  Sun, Hongning;  Li, Mengqi; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:13.2/14.6 | Submit date:2024/02/22
Chemo-immunotherapy  Hitchhiking Delivery  Immunogenic Cell Death  Liposomes  Sting  
A DNA-Modularized STING Agonist with Macrophage-Selectivity and Programmability for Enhanced Anti-Tumor Immunotherapy Journal article
Chen, Yingzhi, Li, Ruike, Duan, Qiao, Wu, Lingling, Li, Xinyi, Luo, Aoxiang, Zhang, Yongming, Zhao, Na, Cui, Kai, Wu, Wenwei, Liu, Tize, Wan, Jian Bo, Deng, Liufu, Li, Guiying, Hou, Lijun, Tan, Weihong, Xiao, Zeyu. A DNA-Modularized STING Agonist with Macrophage-Selectivity and Programmability for Enhanced Anti-Tumor Immunotherapy[J]. Advanced Science, 2024, 11(32).
Authors:  Chen, Yingzhi;  Li, Ruike;  Duan, Qiao;  Wu, Lingling;  Li, Xinyi; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:14.3/16.3 | Submit date:2024/07/04
Aptamer  Cancer Immunotherapy  Cgas-sting  Dna Nanotechnology  Drug Delivery  Tumor-associated Macrophages  
Mesenchymal Stromal Cells Increase the Natural Killer Resistance of Circulating Tumor Cells via Intercellular Signaling of cGAS-STING-IFNβ-HLA Journal article
Yi, Ye, Qin, Guihui, Yang, Hongmei, Jia, Hao, Zeng, Qibing, Zheng, Dejin, Ye, Sen, Zhang, Zhiming, Liu, Tzu Ming, Luo, Kathy Qian, Deng, Chu Xia, Xu, Ren He. Mesenchymal Stromal Cells Increase the Natural Killer Resistance of Circulating Tumor Cells via Intercellular Signaling of cGAS-STING-IFNβ-HLA[J]. Advanced Science, 2024, 11(21), 2400888.
Authors:  Yi, Ye;  Qin, Guihui;  Yang, Hongmei;  Jia, Hao;  Zeng, Qibing; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:14.3/16.3 | Submit date:2024/05/16
Cgas-sting-ifnβ-hla Pathway  Circulating Tumor Cells  Mesenchymal Stromal Cells  Natural Killer Cells  
STING directly recruits WIPI2 for autophagosome formation during STING-induced autophagy Journal article
Wan,Wei, Qian,Chuying, Wang,Qian, Li,Jin, Zhang,Hongtao, Wang,Lei, Pu,Maomao, Huang,Yewei, He,Zhengfu, Zhou,Tianhua, Shen,Han Ming, Liu,Wei. STING directly recruits WIPI2 for autophagosome formation during STING-induced autophagy[J]. EMBO Journal, 2023, 42(8), e112387.
Authors:  Wan,Wei;  Qian,Chuying;  Wang,Qian;  Li,Jin;  Zhang,Hongtao; et al.
Favorite | TC[WOS]:28 TC[Scopus]:28  IF:9.4/11.0 | Submit date:2023/08/03
Autophagy  Cgas  Cytoplasmic Dna  Sting  Wipi2  
STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape Journal article
Kong,Xiangjun, Zuo,Huali, Huang,Hsien Da, Zhang,Qianru, Chen,Jiayu, He,Chengwei, Hu,Yuanjia. STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape[J]. Journal of Advanced Research, 2023, 44, 119-133.
Authors:  Kong,Xiangjun;  Zuo,Huali;  Huang,Hsien Da;  Zhang,Qianru;  Chen,Jiayu; et al.
Favorite | TC[WOS]:31 TC[Scopus]:29  IF:11.4/11.0 | Submit date:2023/08/03
Agonists  Cancer Immunotherapy  Clinical Development  Patent Citation Network  Patent Landscape  Stimulator Of Interferon Genes (Sting)  
STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape Journal article
Xiangjun Kong, Huali Zuo, Hsien-Da Huang, Qianru Zhang, Jiayu Chen, Chengwei He, Yuanjia Hu. STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape[J]. Journal of Advanced Research, 2022, 44, 119-133.
Authors:  Xiangjun Kong;  Huali Zuo;  Hsien-Da Huang;  Qianru Zhang;  Jiayu Chen; et al.
Favorite | TC[WOS]:31 TC[Scopus]:29  IF:11.4/11.0 | Submit date:2022/08/05
Stimulator Of Interferon Genes (Sting)  Patent Landscape  Patent Citation Network  Agonists  Cancer Immunotherapy  Clinical Development  
Manganese-phenolic nanoadjuvant combines sonodynamic therapy with cGAS-STING activation for enhanced cancer immunotherapy Journal article
Tian, Hao, Wang, Guohao, Sang, Wei, Xie, Lisi, Zhang, Zhan, Li, Wenxi, Yan, Jie, Tian, Ye, Li, Jie, Li, Bei, Dai, Yunlu. Manganese-phenolic nanoadjuvant combines sonodynamic therapy with cGAS-STING activation for enhanced cancer immunotherapy[J]. Nano Today, 2022, 43, 101405.
Authors:  Tian, Hao;  Wang, Guohao;  Sang, Wei;  Xie, Lisi;  Zhang, Zhan; et al.
Favorite | TC[WOS]:97 TC[Scopus]:101  IF:13.2/14.6 | Submit date:2022/05/04
Cgas-sting Pathway  Dcs Maturation  Nanoadjuvant  Pd-l1 Checkpoint Blockade Immunotherapy  Sonodynamic Therapy  
Manganese-phenolic nanoadjuvant combines sonodynamic therapy with cGAS-STING activation for enhanced cancer immunotherapy Journal article
Tian, H., Wang, G., Sang, w., Xie, L., Zhang, Z., Li, W., Yan, J., Tian, Y., Li, J., Li, B., Dai, Y.. Manganese-phenolic nanoadjuvant combines sonodynamic therapy with cGAS-STING activation for enhanced cancer immunotherapy[J]. Nano Today, 2022, 101405-101405.
Authors:  Tian, H.;  Wang, G.;  Sang, w.;  Xie, L.;  Zhang, Z.; et al.
Favorite |   IF:13.2/14.6 | Submit date:2023/08/08
Nanoadjuvant  Sonodynamic therapy  cGAS-STING pathway  DCs maturation  PD-L1 checkpoint blockade immunotherapy